SNX30 activators encompass a diverse group of chemical compounds that work through various signaling pathways to enhance the functional activity of SNX30, a protein implicated in endosomal sorting and trafficking. One activation mechanism involves the direct stimulation of adenylyl cyclase, leading to elevated cyclic AMP levels, a critical second messenger in cellular signaling. This increase in cAMP, achieved through either adrenergic receptor agonism or inhibition of phosphodiesterases, can potentiate the function of SNX30 in its associated pathways. Another method of activation is through the modulation of cGMP levels, either by promoting its production via nitric oxide-related signaling or by preventing its degradation through selective phosphodiesterase inhibition. The resulting rise in cGMP can similarly facilitate SNX30's role in the endocytic pathway by influencing downstream protein kinases that govern cargo sorting.
Moreover, activators that alter intracellular calcium dynamics offer an indirect route to modulate SNX30 activity. By increasing cytosolic calcium concentrations, either by facilitating its influx or by inhibiting its sequestration into organelles, these compounds can trigger calcium-dependent signaling cascades that intersect with SNX30-mediated processes. This modulation of calcium signaling is capable of influencing the intricate network of interactions and functions in which SNX30 is involved, particularly those related to the dynamic regulation of endosomal sorting and trafficking.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
A non-selective beta-adrenergic agonist that elevates cAMP levels, potentially enhancing SNX30 function in endosomal sorting. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Phosphodiesterase inhibitor that prevents cAMP breakdown, possibly leading to improved SNX30-mediated signaling. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Selective phosphodiesterase-4 inhibitor, increases cAMP levels thereby potentially increasing SNX30 activity in cells. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
Activates G protein-coupled receptors coupled to cAMP production, which may amplify SNX30 driven endosomal processes. | ||||||
(±)-S-Nitroso-N-acetylpenicillamine | 79032-48-7 | sc-200319B sc-200319 sc-200319A | 10 mg 20 mg 100 mg | $74.00 $114.00 $374.00 | 18 | |
Releases nitric oxide which activates guanylyl cyclase, increasing cGMP that may indirectly support SNX30 endosomal function. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
A cAMP analog that activates PKA, potentially enhancing the role of SNX30 in endosomal sorting and trafficking. | ||||||
8-Bromo-cGMP | 51116-01-9 | sc-200316 sc-200316A | 10 mg 50 mg | $104.00 $354.00 | 7 | |
A cGMP analog that can activate PKG, possibly facilitating SNX30's involvement in endosomal cargo sorting and trafficking. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
Ionophore that increases intracellular calcium, potentially triggering SNX30-mediated endosomal sorting via calcium signaling. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
SERCA pump inhibitor leading to increased cytosolic calcium, which may indirectly enhance SNX30 function in cargo sorting. | ||||||